Advice
About this briefing
Medtech innovation briefings summarise the published evidence and information available for individual medical technologies. The briefings provide information to aid local decision‑making by clinicians, managers and procurement professionals.
Medtech innovation briefings aim to present information and critically review the strengths and weaknesses of the relevant evidence, but contain no recommendations and are not formal NICE guidance.
Development of this briefing
This briefing was developed for NICE by Cedar. The interim process & methods statement sets out the process NICE uses to select topics, and how the briefings are developed, quality‑assured and approved for publication.
Peer reviewers and contributors
-
Ruth Poole, Researcher, Cedar
-
Kathleen Withers, Researcher, Cedar
-
Dr James Evans, Researcher, Cedar
-
Dr Helen Morgan, Information Specialist, Cedar
-
Dr Grace Carolan‑Rees, Director, Cedar
Specialist commentators
The following specialist commentators provided comments on a draft of this briefing:
-
Mr J Vince Smyth, Consultant Vascular and Endovascular Surgeon, Central Manchester University Hospitals NHS Foundation Trust.
-
Mr Eric Chemla, Consultant Renal Transplant and Vascular Surgeon, St George's University Hospitals NHS Foundation Trust.
-
Professor Charles McCollum, Professor of Surgery and Consultant Vascular Surgeon, South Manchester University Hospital NHS Trust.
Declarations of interest
-
Mr Eric Chemla has organised workshops with W L Gore, but paid the honorarium into the hospital research fund.
-
No other relevant conflicts of interest were declared.
Copyright
© National Institute for Health and Care Excellence, 2015. All rights reserved. NICE copyright material can be downloaded for private research and study, and may be reproduced for educational and not‑for‑profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the written permission of NICE.
ISBN: 978‑1‑4731‑1471‑5